Ben Van Camp
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Oncology top 2%
- Bone health and treatments
- Peptidase Inhibition and Analysis
- Chemokine receptors and signaling
Papers in
- Hematology 43
- Multiple Myeloma Research and Treatments 41
-
- Glycosylation and Glycoproteins Research 10
- Protein Degradation and Inhibitors 7
- Ubiquitin and proteasome pathways 5
- Co-authors
- Karin Vanderkerken (44 shared papers)Ivan Van Riet (31 shared papers)Kewal Asosingh (19 shared papers)Peter I. Croucher (14 shared papers)Hendrik De Raeve (17 shared papers)Eline Menu (21 shared papers)Els Van Valckenborgh (18 shared papers)Isabelle Vande Broek (11 shared papers)
- Journals
- Blood (8 papers)British Journal of Haematology (5 papers)American Journal of Clinical Pathology (4 papers)Clinical & Experimental Metastasis (3 papers)International Journal of Cancer (3 papers)
- Partner nations
- BelgiumUnited KingdomUnited States
In The Last Decade
Ben Van Camp
56 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 82
- Hematology 1.3k
- Oncology 1.1k
- Immunology and Allergy 192
- Genetics 239
- Cancer Research 320
Countries citing papers authored by Ben Van Camp
This map shows the geographic impact of Ben Van Camp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Van Camp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Van Camp more than expected).
Fields of papers citing papers by Ben Van Camp
This network shows the impact of papers produced by Ben Van Camp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Van Camp. The network helps show where Ben Van Camp may publish in the future.
Co-authors
The 25 scholars most cited alongside Ben Van Camp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 214 | |
| 2 | Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma. | 2003 | 146 |
| 3 | 1994 | 120 | |
| 4 | 2010 | 116 | |
| 5 | 2000 | 110 | |
| 6 | 2005 | 107 | |
| 7 | 2003 | 92 | |
| 8 | 2011 | 91 | |
| 9 | 2006 | 90 | |
| 10 | 2013 | 72 | |
| 11 | 2011 | 71 | |
| 12 | 1999 | 71 | |
| 13 | Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival. | 2006 | 69 |
| 14 | 2000 | 62 | |
| 15 | 2009 | 57 | |
| 16 | 1989 | 56 | |
| 17 | 2007 | 56 | |
| 18 | 1993 | 52 | |
| 19 | 2013 | 51 | |
| 20 | 2013 | 50 |
About Ben Van Camp
Ben Van Camp is a scholar working on Hematology, Molecular Biology, Oncology, Immunology and Allergy and Cancer Research, having authored 58 papers that have together received 2.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (41 papers), Glycosylation and Glycoproteins Research (10 papers), Cell Adhesion Molecules Research (10 papers), Chemokine receptors and signaling (9 papers), Protein Degradation and Inhibitors (7 papers), Bone health and treatments (6 papers), Ubiquitin and proteasome pathways (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Hematology (1.3k citations), Oncology (1.1k citations), Immunology and Allergy (192 citations), Genetics (239 citations) and Cancer Research (320 citations). Ben Van Camp has collaborated with scholars based in Belgium, United Kingdom and United States. Frequent co-authors include Karin Vanderkerken, Ivan Van Riet, Kewal Asosingh, Peter I. Croucher, Hendrik De Raeve, Eline Menu, Els Van Valckenborgh, Isabelle Vande Broek, C M Shipman and Marleen Bâkkus. Their work appears in journals such as Blood, British Journal of Haematology, American Journal of Clinical Pathology, Clinical & Experimental Metastasis and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.